Characteristics and outcome of human immunodeficiency virus (HIV)-associated primary effusion lymphoma as observed in the German HIV-related lymphoma cohort study

Br J Haematol. 2021 Aug;194(3):642-646. doi: 10.1111/bjh.17515. Epub 2021 May 7.

Marcus Hentrich¹, Markus Müller², Christoph Wyen^{3

4}, Johannes Bogner⁵, Henrike Thomssen⁶, Jan-Christian Wasmuth⁷, Timo Wolf⁸, Christian Hoffmann^{9

10}, Philipp Schommers^{4

11}

¹ Department of Medicine III - Hematology and Oncology, Red Cross Hospital Munich, Munich, Germany.
² Department of Infectiology, St. Joseph Hospital, Berlin, Germany.
³ Praxis Am Ebertplatz, Cologne, Germany.
⁴ Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁵ Department of Medicine IV, Ludwig-Maximilians University of Munich, Munich, Germany.
⁶ Department of Hematology and Oncology, Hospital Bremen Mitte, Bremen, Germany.
⁷ Department of Medicine I, University of Bonn, Bonn, Germany.
⁸ Department of Medicine III, University Hospital Frankfurt, Frankfurt, Germany.
⁹ ICH Study Center Hamburg, Hamburg, Germany.
¹⁰ Department of Medicine II, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
¹¹ Partner Site Bonn-Cologne, German Center for Infection Research (DZIF), Cologne, Germany.

No abstract available

Keywords: AIDS; HIV; HIV-associated lymphoma; primary effusion lymphoma.

Publication types